Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.77%Interest Expense Margin
VS
Market
Sector
Industry
History
$ 1.86Close
$ 1.02 - $ 3.07 52-Week Range
Ticker Information
Ticker
PLXCompany Name
PROTALIX BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTPROTALIX BIOTHERAPEUTICS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
PLX - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 1.09M | 1.77% | $ 61.95M |
| 3/31/2025 | $ 678K | 1.13% | $ 59.76M |
| 12/31/2024 | $ 1.06M | 1.99% | $ 53.4M |
| 9/30/2024 | $ 544K | 1.19% | $ 45.67M |
| 6/30/2024 | $ 705K | 1.85% | $ 38.05M |
| 3/31/2024 | $ 1.64M | 2.75% | $ 59.65M |
| 12/31/2023 | $ 1.89M | 2.89% | $ 65.49M |
| 9/30/2023 | $ 2.96M | 4.65% | $ 63.63M |
| 6/30/2023 | $ 2.94M | 4.36% | $ 67.46M |
| 3/31/2023 | $ 2.26M | 5.49% | $ 41.14M |
Key Performance Insights, Last 5 Years
- PROTALIX BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 14.22%.
- Over the past 5 years, PROTALIX BIOTHERAPEUTICS INC's average Int. Exp. % has been 7.8%.
- The median Int. Exp. % for PROTALIX BIOTHERAPEUTICS INC during this period was 4.84%
- PROTALIX BIOTHERAPEUTICS INC reached its highest Int. Exp. % over the past 5 years at 18.57%.
- The lowest Int. Exp. % recorded by PROTALIX BIOTHERAPEUTICS INC in the same timeframe 1.13%
PROTALIX BIOTHERAPEUTICS INC's Int. Exp. % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Int. Exp. % Benchmarks
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for PROTALIX BIOTHERAPEUTICS INC is calculated as follows: Int. Exp. [ $ 8.7M ] / Revenues [ $ 61.16M ]
(=) Int. Exp. % [ 14.22% ] PLX - Interest Expense Margin, Last 5 years
1.13%
Minimum
Mar 31, 2025
18.57%
Maximum
Dec 31, 2021
7.8%
Average
4.84%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |